The Role of Systemic Antibiotics in Periodontal Diseases

Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontology 2000 2002; 28: 106-176.

Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. The lancet 2005; 366: 1809-1820.

Hojo K, Nagaoka S, Ohshima T, Maeda N. Bacterial interactions in dental biofilm development. Journal of dental research 2009; 88: 982-990.

Jakubovics NS, Goodman SD, Mashburn‐Warren L, Stafford GP, Cieplik F. The dental plaque biofilm matrix. Periodontology 2000 2021; 86: 32-56.

Greenstein G. Changing periodontal concepts: treatment considerations. Compendium of continuing education in dentistry (Jamesburg, NJ: 1995) 2005; 26: 81-82, 84.

Wang H-Y, Cheng J-W, Yu H-Y, Lin L, Chih Y-H, Pan Y-P. Efficacy of a novel antimicrobial peptide against periodontal pathogens in both planktonic and polymicrobial biofilm states. Acta Biomaterialia 2015; 25: 150-161.

Walker C, Karpinia K. Rationale for use of antibiotics in periodontics. Journal of periodontology 2002; 73: 1188-1196.

Herrera D, Alonso B, León R, Roldán S, Sanz M. Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm. Journal of clinical periodontology 2008; 35: 45-66.

Genco RJ. Host responses in periodontal diseases: current concepts. Journal of periodontology 1992; 63: 338-355.

Golub LM, Lee HM. Periodontal therapeutics: Current host‐modulation agents and future directions. Periodontology 2000 2020; 82: 186-204.

Feres M, Haffajee A, Goncalves C, et al. Systemic doxycycline administration in the treatment of periodontal infections (I) Effect on the subgingival microbiota. Journal of clinical periodontology 1999; 26: 775-783.

Rateitschak‐Plüss EM, Schwarz JP, Guggenheim R, Duggelin M, Rateitschak KH. Non‐surgical periodontal treatment: Where are the limits? An SEM study. Journal of clinical periodontology 1992; 19: 240-244.

Pertuiset J, Saglie F, Lofthus J, Rezende M, Sanz M. Recurrent periodontal disease and bacterial presence in the gingiva. Journal of Periodontology 1987; 58: 553-558.

Feres M, Figueiredo LC, Soares GMS, Faveri M. Systemic antibiotics in the treatment of periodontitis. Periodontology 2000 2015; 67: 131-186.

Slots J. Systemic antibiotics in periodontics. Journal of periodontology 2004; 75: 1553-1565.

Keestra J, Grosjean I, Coucke W, Quirynen M, Teughels W. Non‐surgical periodontal therapy with systemic antibiotics in patients with untreated chronic periodontitis: a systematic review and meta‐analysis. Journal of periodontal research 2015; 50: 294-314.

Genrx, Schrefer J, Nissen D. Mosby's GenRx: A Comprehensive Reference for Generic and Brand Prescription Drugs: Mosby, 2001.

Ardila CM, Bedoya‐García JA, Arrubla‐Escobar DE. Antibiotic resistance in periodontitis patients: A systematic scoping review of randomized clinical trials. Oral diseases 2023; 29: 2501-2511.

Carr VR, Witherden EA, Lee S, et al. Abundance and diversity of resistomes differ between healthy human oral cavities and gut. Nature communications 2020; 11: 693.

Shah S, Wordley V, Thompson W. How did COVID-19 impact on dental antibiotic prescribing across England? British Dental Journal 2020; 229: 601-604.

Slama T, Amin A, Brunton S, File Tm Jr MG, Rodvold K. Council for Appropriate and Rational Antibiotic Therapy (CARAT). A clinician's guide to the appropriate and accurate use of antibiotics: The council for appropriate and Rational Antibiotic Therapy (CARAT) criteria. Am J Med 2005; 118: 1S-6S.

Sanz M, Herrera D, Kebschull M, et al. Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline. Journal of clinical periodontology 2020; 47: 4-60.

Soares GMS, Figueiredo LC, Faveri M, Cortelli SC, Duarte PM, Feres M. Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs. Journal of applied oral science 2012; 20: 295-309.

Prakasam A, Elavarasu SS, Natarajan RK. Antibiotics in the management of aggressive periodontitis. Journal of pharmacy & bioallied sciences 2012; 4: S252.

Teughels W, Feres M, Oud V, Martín C, Matesanz P, Herrera D. Adjunctive effect of systemic antimicrobials in periodontitis therapy: A systematic review and meta‐analysis. Journal of Clinical Periodontology 2020; 47: 257-281.

Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy: a review. Jama 2019; 321: 188-199.

Ardila C-M, Bedoya-García J-A. Antimicrobial resistance of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis and Tannerella forsythia in periodontitis patients. Journal of global antimicrobial resistance 2020; 22: 215-218.

Kulik EM, Thurnheer T, Karygianni L, Walter C, Sculean A, Eick S. Antibiotic susceptibility patterns of aggregatibacter actinomycetemcomitans and porphyromonas gingivalis strains from different decades. Antibiotics 2019; 8: 253.

Mínguez M, Ennibi O, Perdiguero P, et al. Antimicrobial susceptibilities of Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis strains from periodontitis patients in Morocco. Clinical Oral Investigations 2019; 23: 1161-1170.

Walker CB, Karpinia K, Baehni P. Chemotherapeutics: antibiotics and other antimicrobials. Periodontology 2000 2004; 36.

Rooney J, Wade W, Sprague S, Newcombe R, Addy M. Adjunctive effects to non‐surgical periodontal therapy of systemic metronidazole and amoxycillin alone and combined: A placebo controlled study. Journal of clinical periodontology 2002; 29: 342-350.

Walker C, Tyler K, Low S, King C. Penicillin‐degrading enzymes in sites associated with adult periodontitis. Oral Microbiology and Immunology 1987; 2: 129-131.

Haffajee A, Dibart S, Kent Jr R, Socransky S. Clinical and microbiological changes associated with the use of 4 adjunctive systemically administered agents in the treatment of periodontal infections. Journal of clinical periodontology 1995; 22: 618-627.

Magnusson I, Clark W, Low S, Maruniak J, Marks B, Walker C. Effect of non‐surgical periodontal therapy combined with adjunctive antibiotics in subjects with “refractory” periodontal disease: (I). Clinical results. Journal of Clinical Periodontology 1989; 16: 647-653.

Suárez LJ, Arce RM, Gonçalves C, et al. Metronidazole may display anti‐inflammatory features in periodontitis treatment: A scoping review. Molecular Oral Microbiology 2024.

Seymour R, Heasman P. Pharmacological control of periodontal disease. II. Antimicrobial agents. Journal of Dentistry 1995; 23: 5-14.

Ahmadi H, Ebrahimi A, Ahmadi F. Antibiotic therapy in dentistry. International journal of dentistry 2021; 2021: 6667624.

Heitz‐Mayfield L. Systemic antibiotics in periodontal therapy. Australian dental journal 2009; 54: S96-S101.

Larsen T. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral microbiology and immunology 2002; 17: 267-271.

Herrera D, Matesanz P, Bascones-Martínez A, Sanz M. Local and systemic antimicrobial therapy in periodontics. Journal of Evidence Based Dental Practice 2012; 12: 50-60.

Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti‐infective periodontal therapy. A systematic review. Annals of Periodontology 2003; 8: 115-181.

Ghayoumi N. The use of metronidazole in the treatment of periodontal diseases The Journal of the Western Society of Periodontology/periodontal Abstracts, 2001: 37-40.

Wade DN, Kerns DG. Acute necrotizing ulcerative gingivitis-periodontitis: a literature review. Military medicine 1998; 163: 337-342.

Kherul Anuwar AH, Saub R, Safii SH, et al. Systemic antibiotics as an adjunct to subgingival debridement: a network meta-analysis. Antibiotics 2022; 11: 1716.

Dahlen G, Preus H. Low antibiotic resistance among anaerobic Gram-negative bacteria in periodontitis 5 years following metronidazole therapy. Anaerobe 2017; 43: 94-98.

Loesche WJ, Giordano JR, Hujoel P, Schwarcz J, Smith BA. Metronidazole in periodontitis: reduced need for surgery. Journal of clinical periodontology 1992; 19: 103-112.

Feres M, Soares GMS, Mendes JAV, et al. Metronidazole alone or with amoxicillin as adjuncts to non‐surgical treatment of chronic periodontitis: a 1‐year double‐blinded, placebo‐controlled, randomized clinical trial. Journal of clinical periodontology 2012; 39: 1149-1158.

Haffajee AD, Torresyap G, Socransky SS. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1‐year results. Journal of clinical periodontology 2007; 34: 243-253.

Benz L, Winkler P, Dannewitz B, et al. Additional benefit of systemic antibiotics in subgingival instrumentation of stage III and IV periodontitis with Aggregatibacter actinomycetemcomitans: A retrospective analysis. Journal of Clinical Periodontology 2023; 50: 684-693.

Nibali L, Koidou VP, Hamborg T, Donos N. Empirical or microbiologically guided systemic antimicrobials as adjuncts to non‐surgical periodontal therapy? A systematic review. Journal of clinical periodontology 2019; 46: 999-1012.

Kurian M, Ganapathy D, Jain AR. Recent advances of metronidazole-A review. Drug Invention Today 2018; 10.

Khattri S, Nagraj SK, Arora A, et al. Adjunctive systemic antimicrobials for the non‐surgical treatment of periodontitis. Cochrane Database of Systematic Reviews 2020.

Jepsen K, Jepsen S. Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis. Periodontology 2000 2016; 71: 82-112.

Goodson JM. Antimicrobial strategies for treatment of periodontal diseases. Periodontology 2000 1994; 5: 142-168.

Kopra E, Lahdentausta L, Pietiäinen M, et al. Systemic antibiotics influence periodontal parameters and oral microbiota, but not serological markers. Frontiers in Cellular and Infection Microbiology 2021; 11: 774665.

Dukić S, Matijević S, Daković D, Čutović T. Comparison of cefixime and amoxicillin plus metronidazole in the treatment of chronic periodontitis. Vojnosanitetski pregled 2016; 73: 526-530.

Campagna JD, Bond MC, Schabelman E, Hayes BD. The use of cephalosporins in penicillin-allergic patients: a literature review. The Journal of emergency medicine 2012; 42: 612-620.

Heta S, Robo I. The side effects of the most commonly used group of antibiotics in periodontal treatments. Medical Sciences 2018; 6: 6.

Rusu A, Buta EL. The development of third-generation tetracycline antibiotics and new perspectives. Pharmaceutics 2021; 13: 2085.

Gordon J, Walker C, Murphy J, Goodson J, Socransky S. Concentration of tetracycline in human gingival fluid after single doses. Journal of Clinical Periodontology 1981; 8: 117-121.

Walker C, Gordon J, McQuilkin S, Niebloom T, Socransky S. Tetracycline: Levels Achievable in Gingival Crevice Fluid and in Vitro Effect on Subgingival Organisms: Part II. Susceptibilities of Periodontal Bacteria. Journal of periodontology 1981; 52: 613-616.

Raja M, Ummer F, Dhivakar C. Aggregatibacter actinomycetemcomitans–a tooth killer? Journal of clinical and diagnostic research: JCDR 2014; 8: ZE13.

Slots J, Mashimo P, Levine M, Genco R. Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy. Journal of periodontology 1979; 50: 495-509.

Herrera D, Sanz M, Jepsen S, Needleman I, Roldán S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. Journal of clinical periodontology 2002; 29: 136-159.

Novak MJ, Polson AM, Adair SM. Tetracycline therapy in patients with early juvenile periodontitis. Journal of Periodontology 1988; 59: 366-372.

Novak MJ, Stamatelakys C, Adair SM. Resolution of early lesions of juvenile periodontitis with tetracycline therapy alone: long‐term observations of 4 cases. Journal of periodontology 1991; 62: 628-633.

Sakellari D, Goodson J, Socransky S, Kolokotronis A, Konstantinidis A. Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva. Journal of clinical periodontology 2000; 27: 53-60.

van Winkelhoff AJ, Tijhof CJ, De Graaff J. Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans‐associated periodontitis. Journal of periodontology 1992; 63: 52-57.

Baltacioglu E, Aslan M, Saraç Ö, Saybak A, Yuva P. Analysis of clinical results of systemic antimicrobials combined with nonsurgical periodontal treatment for generalized aggressive periodontitis: a pilot study. Journal of the Canadian Dental Association 2011; 77: 227.

Luan J, Li R, Xu W, et al. Functional biomaterials for comprehensive periodontitis therapy. Acta Pharmaceutica Sinica B 2023; 13: 2310-2333.

Caton J, Ryan ME. Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD). Pharmacological research 2011; 63: 114-120.

Golub LM, Elburki MS, Walker C, et al. Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases. International dental journal 2016; 66: 127-135.

Cianfrocca M, Cooley TP, Lee JY, et al. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi’s sarcoma: a phase I AIDS malignancy consortium study. Journal of clinical oncology 2002; 20: 153-159.

Ryan M, Lee H, Tenzler R, Carnu O, Eftekhari S, Dhami A. Effects of short-term COL-3 on local biomarkers of periodontitis. J Dent Res 2008; 87.

Swamy DN, Sanivarapu S, Moogla S, Kapalavai V. Chemically modified tetracyclines: The novel host modulating agents. Journal of Indian Society of Periodontology 2015; 19: 370-374.

Sawhney A. Chemically modified tetracyclines, Periodontology and Dental Implantology: IntechOpen, 2019.

Ramberg P, Rosling B, Serino G, Hellström M, Socransky S, Lindhe J. The long‐term effect of systemic tetracycline used as an adjunct to non‐surgical treatment of advanced periodontitis. Journal of Clinical Periodontology 2001; 28: 446-452.

Herrera D, van Winkelhoff AJ, Matesanz P, Lauwens K, Teughels W. Europe's contribution to the evaluation of the use of systemic antimicrobials in the treatment of periodontitis. Periodontology 2000 2023.

Warner AJ, Hathaway-Schrader JD, Lubker R, Davies C, Novince CM. Tetracyclines and bone: Unclear actions with potentially lasting effects. Bone 2022; 159: 116377.

Winkelhoff AJV, Rams TE, Slots J. Systemic antibiotic therapy in periodontics. Periodontology 2000 1996; 10: 45-78.

Zaharescu A, Mârțu I, Luchian A-I, et al. Role of adjunctive therapy with subantimicrobial doses of doxycycline in glycemic control (HbA1c) in patients with diabetes and endo‑periodontal lesions to prevent sinus complications. Experimental and Therapeutic Medicine 2021; 21: 1-1.

Basegmez C, Berber L, Yalcin F. Clinical and biochemical efficacy of minocycline in nonsurgical periodontal therapy: a randomized controlled pilot study. The Journal of Clinical Pharmacology 2011; 51: 915-922.

Frazão DR, Matos-Souza JM, Dos Santos VRN, et al. Minocycline reduces alveolar bone loss and bone damage in Wistar rats with experimental periodontitis. Plos one 2024; 19: e0309390.

Haskes C, Shea M, Imondi D. Minocycline-induced scleral and dermal hyperpigmentation. Optometry and Vision Science 2017; 94: 436-442.

Martins AM, Marto JM, Johnson JL, Graber EM. A review of systemic minocycline side effects and topical minocycline as a safer alternative for treating acne and rosacea. Antibiotics 2021; 10: 757.

Dinos GP. The macrolide antibiotic renaissance. British journal of pharmacology 2017; 174: 2967-2983.

Pappas J, Walker C. Gingival crevicular fluid levels of erythromycin and the in vitro effect on periodontal bacteria. J Dent Res 1987; 66: 154.

Rotzetter PA, Le Liboux A, Pichard E, Cimasoni G. Kinetics of spiramycin/metronidazole (Rodogyl®) in human gingival crevicular fluid, saliva and blood. Journal of clinical periodontology 1994; 21: 595-600.

Bain C, Beagrie G, Bourgoin J, et al. The effects of spiramycin and/or scaling on advanced periodontitis in humans. Journal (Canadian Dental Association) 1994; 60: 209, 212-207.

Al‐Joburi W, Chin Quee T, Lautar C, et al. Effects of adjunctive treatment of periodontitis with tetracycline and spiramycin. Journal of Periodontology 1989; 60: 533-539.

Raghunatha K, George JP. Periodontal tissue and serum concentration of clarithromycin after systemic administration in patients affected by chronic periodontitis. Journal of Periodontology 2013; 84: e17-e22.

Iskandar I, Walters JD. Clarithromycin accumulation by phagocytes and its effect on killing of Aggregatibacter actinomycetemcomitans. Journal of periodontology 2011; 82: 497-504.

Suryaprasanna J, Radhika PL, Karunakar P, et al. Evaluating the effectiveness of clarithromycin as an adjunct to scaling and root planing: a randomized clinical trial. Journal of Indian Society of Periodontology 2018; 22: 529-534.

Andere NMRB, Castro dos Santos NC, Araujo CF, et al. Clarithromycin as an adjunct to one‐stage full‐mouth ultrasonic periodontal debridement in generalized aggressive periodontitis: a randomized controlled clinical trial. Journal of periodontology 2017; 88: 1244-1252.

Bashir NZ, Sharma P. Clarithromycin as an adjunct to periodontal therapy: a systematic review and meta‐analysis. International Journal of Dental Hygiene 2022; 20: 75-86.

Malizia T, Tejada MR, Ghelardi E, et al. Periodontal tissue disposition of azithromycin. Journal of periodontology 1997; 68: 1206-1209.

Hirsch R, Deng H, Laohachai M. Azithromycin in periodontal treatment: more than an antibiotic. Journal of periodontal research 2012; 47: 137-148.

Hayes E, McSorley R. Systemic antimicrobials as an adjunct in the management of periodontitis–which drug is best? Evidence-Based Dentistry 2024: 1-2.

Atieh M, Shah M, Hakam A, Alghafri M, Tawse‐Smith A, Alsabeeha N. Systemic azithromycin versus amoxicillin/metronidazole as an adjunct in the treatment of periodontitis: a systematic review and meta‐analysis. Australian dental journal 2024; 69: 4-17.

Haas AN, De Castro GD, Moreno T, et al. Azithromycin as an adjunctive treatment of aggressive periodontitis: 12‐months randomized clinical trial. Journal of clinical periodontology 2008; 35: 696-704.

Sampaio E, Rocha M, Figueiredo LC, et al. Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo‐controlled clinical trial. Journal of clinical periodontology 2011; 38: 838-846.

Jones OP, Hoyle PJ. Azithromycin as an adjunct to subgingival professional mechanical plaque removal in the treatment of grade C periodontitis: a systematic review and meta-analysis. Journal of Periodontal & Implant Science 2022; 52: 352.

Fuchs MD, Signer-Buset SL, Mendes S, Schmidt JC, Walter C. Does systemically administered azithromycin have an effect on gingival overgrowth? A systematic review. Oral surgery, oral medicine, oral pathology and oral radiology 2019; 128: 606-614. e601.

Paik JW, Kim CS, Cho KS, Chai JK, Kim CK, Choi SH. Inhibition of cyclosporin A‐induced gingival overgrowth by azithromycin through phagocytosis: an in vivo and in vitro study. Journal of periodontology 2004; 75: 380-387.

Patel PH, Hashmi MF. Macrolides, StatPearls [Internet]: StatPearls Publishing, 2023.

Rubinstein E. Comparative safety of the different macrolides. International journal of antimicrobial agents 2001; 18: 71-76.

Luchian I, Goriuc A, Martu MA, Covasa M. Clindamycin as an alternative option in optimizing periodontal therapy. Antibiotics 2021; 10: 814.

Addy L, Martin M. Clindamycin and dentistry. British dental journal 2005; 199: 23-26.

Nicholas P, Meyers BR, Levy RN, Hirschman SZ. Concentration of clindamycin in human bone. Antimicrobial agents and chemotherapy 1975; 8: 220-221.

Bystedt H, Dahlbäck A, Dornbusch K, Nord C. Concentrations of azidocillin, erythromycin, doxycycline and clindamycin in human mandibular bone. International journal of oral surgery 1978; 7: 442-449.

Kapoor A, Malhotra R, Grover V, Grover D. Systemic antibiotic therapy in periodontics. Dental research journal 2012; 9: 505.

Merriam CV, Citron DM, Tyrrell KL, Warren YA, Goldstein EJ. In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens. International journal of antimicrobial agents 2006; 28: 244-248.

Gordon J, Walker C, Lamster I, et al. Efficacy of clindamycin hydrochloride in refractory periodontitis: 12‐month results. Journal of periodontology 1985; 56: 75-80.

Gómez-Sandoval JR, Robles-Cervantes JA, Hernández-González SO, et al. Efficacy of clindamycin compared with amoxicillin-metronidazole after a 7-day regimen in the treatment of periodontitis in patients with diabetes: a randomized clinical trial. BMJ Open Diabetes Research and Care 2020; 8: e000665.

Vidyavathi M, Srividya G. A review on ciprofloxacin: dosage form perspective. International Journal of Applied Pharmaceutics 2018; 10: 6-10.

Tripathi K. Essentials of medical pharmacology: Jaypee brothers medical publishers, 2018.

Slots J, Feik D, Rams TE. In vitro antimicrobial sensitivity of enteric rods and pseudomonads from advanced adult periodontitis. Oral microbiology and immunology 1990; 5: 298-301.

Tanner A, Maiden MF, Paster BJ, Dewhirst FE. The impact of 16S ribosomal RNA‐based phylogeny on the taxonomy of oral bacteria. Periodontology 2000 1994; 5: 26-51.

Rams T, Feik D, Slots J. Ciprofloxacin/metronidazole treatment of recurrent adult periodontitis. J Dent Res 1992; 71: 319.

TÖZüM TF, Yildirim A, Cağlayan F, Dinçel A, Bozkurt A. Serum and gingival crevicular fluid levels of ciprofloxacin in patients with periodontitis. The Journal of the American Dental Association 2004; 135: 1728-1732.

Rams TE, Freedman IS, Chialastri SM, Slots J. Systemic ciprofloxacin treatment of multidrug-resistant Aggregatibacter actinomycetemcomitans in severe periodontitis. Diagnostic Microbiology and Infectious Disease 2024; 108: 116162.

Ardila C-M, Bedoya-García J-A. Clinical and microbiological efficacy of adjunctive systemic quinolones to mechanical therapy in periodontitis: a systematic review of the literature. International Journal of Dentistry 2022; 2022: 4334269.

Ardila CM, Martelo‐Cadavid JF, Boderth‐Acosta G, Ariza‐Garcés AA, Guzmán IC. Adjunctive moxifloxacin in the treatment of generalized aggressive periodontitis patients: clinical and microbiological results of a randomized, triple‐blind and placebo‐controlled clinical trial. Journal of Clinical Periodontology 2015; 42: 160-168.

Ardila CM, Flórez-Flórez J, Castañeda-Parra L-D, Guzmán IC, Bedoya-García JA. Moxifloxacin versus amoxicillin plus metronidazole as adjunctive therapy for generalized aggressive periodontitis: a pilot randomized controlled clinical trial. Quintessence International 2020; 51.

Davis R, Markham A, Balfour JA. Ciprofloxacin. Drugs 1996; 51: 1019-1074.

Walker CB. Selected antimicrobial agents: mechanisms of action, side effects and drug interactions. Periodontology 2000 1996; 10: 12-28.

Ellen RP, McCulloch CA. Evidence versus empiricism: rational use of systemic antimicrobial agents for treatment of periodontitis. Periodontology 2000 1996; 10: 29-44.

Newman MG, Takei H, Klokkevold PR, Carranza FA. Newman and Carranza's Clinical periodontology E-book: Elsevier Health Sciences, 2018.

Matisko MW, Bissada NF. Short‐term sequential administration of amoxicillin/clavulanate potassium and doxycycline in the treatment of recurrent/progressive periodontitis. Journal of periodontology 1993; 64: 553-558.

Aitken S, Birek P, Kulkarni G, Lee W, McCulloch C. Serial doxycycline and metronidazole in prevention of recurrent periodontitis in high‐risk patients. Journal of periodontology 1992; 63: 87-92.

Yek EC, Cintan S, Topcuoglu N, Kulekci G, Issever H, Kantarci A. Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. Journal of periodontology 2010; 81: 964-974.

Rams TE, Slots J. Antimicrobial chemotherapy for recalcitrant severe human periodontitis. Antibiotics 2023; 12: 265.

Ebrahimi H, Bakhtyari A, Bamadi M. The effectiveness of adjuvant therapy with ciprofloxacin in non-surgical treatment of severe chronic periodontitis. Journal of Advanced Pharmacy Education and Research 2019; 9: 64-69.